A 70-year-old woman was admitted to our intensive care unit due to COVID-19 pneumonia. She received treatment with remdesivir for five days, two doses of tocilizumab and methylprednisolone (1 mg/kg/day). Patient required intubation and tracheostomy due to myopathy. After nineteen days, patient presented a massive hemoptysis. An urgent bronchoscopy evidenced a non-occlusive clot in the right main bronchus and a pulsatile lesion underneath. The pulmonary artery angiography showed a pseudoaneurysm in a right intercostobronchial trunk (Fig. 1 ) with extravasation of iodinated contrast (red star). Immediate transcatheter exclusion of the pseudoaneurysm was successful. The thoracic CT-scan evidenced the typical COVID-19 pattern with a highly suspicious aspergillus cavity (red arrow) in the right upper lobe pulmonary parenchyma (Figure 2, Figure 3 ). Respiratory secretions cultures were positive for Aspergillus niger so dual antifungal treatment was started. This case illustrates the risk of COVID-19 associated pulmonary aspergillosis (CAPA) and related complications.
Figure 1.
Figure 2.
Figure 3.
Funding
This work has not received any type of funding.
Conflicts of interest
The authors declare that they have no conflict of interest.